Pathological Specimens and Data - What controls should be in place?

  • April 23, 2002
  • Dinner, Discussion
Debate summary (17.7KB)
Dr Robert Coleman
Chief Scientific Officer, Pharmagene Laboratories Ltd
Steve Catling
Chief Executive, The Retained Organs Commission
Professor Nick Wright FMedSci
Warden, Barts Hospital and The London School of Medicine and Dentistry

Cancer Research UK, Department of Health, Medical Research Council, The Wellcome Trust

This discussion appeared in the FST journal below.